Sprangers MAG - Search Results

1

Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals.

Langebeek N, Kooij KW, Wit FW, Stolte IG, Sprangers MAG, Reiss P, Nieuwkerk PT; AGEhIV Cohort Study Group. Langebeek N, et al. Among authors: sprangers mag. AIDS. 2017 Jun 19;31(10):1471-1481. doi: 10.1097/QAD.0000000000001511. AIDS. 2017. PMID: 28574965

2

Longitudinal study on the Quality of Life of symptomatic HIV-infected patients in a trial of zidovudine versus zidovudine and interferon-alpha.

de Boer JB, van Dam FS, Sprangers MA, Frissen PH, Lange JM. de Boer JB, et al. AIDS. 1993 Jul;7(7):947-53. doi: 10.1097/00002030-199307000-00007. AIDS. 1993. PMID: 8357556 Clinical Trial.

3

Health-related quality-of-life evaluation in HIV-infected patients. A review of the literature.

de Boer JB, van Dam FS, Sprangers MA. de Boer JB, et al. Pharmacoeconomics. 1995 Oct;8(4):291-304. doi: 10.2165/00019053-199508040-00004. Pharmacoeconomics. 1995. PMID: 10155671 Review.

4

Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group.

Nieuwkerk PT, Gisolf EH, Colebunders R, Wu AW, Danner SA, Sprangers MA. Nieuwkerk PT, et al. AIDS. 2000 Jan 28;14(2):181-7. doi: 10.1097/00002030-200001280-00014. AIDS. 2000. PMID: 10708289 Clinical Trial.

5

Quality of life in maintenance vs prolonged induction therapy for HIV.

Nieuwkerk PT, Reijers MH, Weigel HM, Lange JM, Sprangers MA. Nieuwkerk PT, et al. JAMA. 2000 Jul 12;284(2):178-9. doi: 10.1001/jama.284.2.178. JAMA. 2000. PMID: 10889587 Clinical Trial. No abstract available.

6

Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response.

Nieuwkerk P, Gisolf E, Sprangers M, Danner S; Prometheus Study Group. Nieuwkerk P, et al. Antivir Ther. 2001 Jun;6(2):97-103. Antivir Ther. 2001. PMID: 11491422 Clinical Trial.

7

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

Nieuwkerk PT, Sprangers MA, Burger DM, Hoetelmans RM, Hugen PW, Danner SA, van Der Ende ME, Schneider MM, Schrey G, Meenhorst PL, Sprenger HG, Kauffmann RH, Jambroes M, Chesney MA, de Wolf F, Lange JM; ATHENA Project. Nieuwkerk PT, et al. Arch Intern Med. 2001 Sep 10;161(16):1962-8. doi: 10.1001/archinte.161.16.1962. Arch Intern Med. 2001. PMID: 11525698

8

Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection.

Nieuwkerk PT, Gisolf EH, Reijers MH, Lange JM, Danner SA, Sprangers MA; NATIVE Study Group; PROMETHEUS Study Group; ADAM Study Group. Nieuwkerk PT, et al. AIDS. 2001 Oct 19;15(15):1985-91. doi: 10.1097/00002030-200110190-00011. AIDS. 2001. PMID: 11600827 Clinical Trial.

9

Patients' preferences regarding the timing of highly active antiretroviral therapy initiation for chronic asymptomatic HIV-1 infection.

Locadia M, van Grieken RA, Prins JM, de Vries HJ, Sprangers MA, Nieuwkerk PT. Locadia M, et al. Antivir Ther. 2006;11(3):335-41. Antivir Ther. 2006. PMID: 16759050

10

Clinical factors associated with quality of life in patients with transient loss of consciousness.

van Dijk N, Sprangers MA, Colman N, Boer KR, Wieling W, Linzer M. van Dijk N, et al. J Cardiovasc Electrophysiol. 2006 Sep;17(9):998-1003. doi: 10.1111/j.1540-8167.2006.00533.x. Epub 2006 Jun 9. J Cardiovasc Electrophysiol. 2006. PMID: 16764705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters